{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T19:15:02Z","timestamp":1793128502304,"version":"4.5.0"},"reference-count":206,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100020207","name":"Health Commission of Sichuan Province","doi-asserted-by":"publisher","award":["24QNMP070"],"award-info":[{"award-number":["24QNMP070"]}],"id":[{"id":"10.13039\/501100020207","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014895","name":"Southwest Medical University","doi-asserted-by":"publisher","award":["2024LCYXZX27"],"award-info":[{"award-number":["2024LCYXZX27"]}],"id":[{"id":"10.13039\/501100014895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.intimp.2025.115578","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T04:11:02Z","timestamp":1758600662000},"page":"115578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Sphingosine-1-phosphate signaling in respiratory diseases: mechanisms and therapeutic perspectives"],"prefix":"10.1016","volume":"166","author":[{"given":"Juan","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyi","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiongqiong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianming","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2025.115578_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2023.101251","article-title":"Sphingosine 1-phosphate signaling during infection and immunity","volume":"92","author":"Mohammed","year":"2023","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.intimp.2025.115578_bb0010","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6041471","article-title":"Associations among S100A4, sphingosine-1-phosphate, and pulmonary function in patients with chronic obstructive pulmonary disease","volume":"2022","author":"Qin","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"8","key":"10.1016\/j.intimp.2025.115578_bb0015","doi-asserted-by":"crossref","first-page":"215892","DOI":"10.1136\/thoraxjnl-2020-215892","article-title":"Ceramide and sphingosine-1 phosphate in COPD lungs","volume":"76","author":"Berdyshev","year":"2021","journal-title":"Thorax."},{"issue":"1","key":"10.1016\/j.intimp.2025.115578_bb0020","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12931-022-01991-1","article-title":"Sphingosine-1-phosphate and CRP as potential combination biomarkers in discrimination of COPD with community-acquired pneumonia and acute exacerbation of COPD","volume":"23","author":"Hsu","year":"2022","journal-title":"Respir. Res."},{"issue":"6","key":"10.1016\/j.intimp.2025.115578_bb0025","doi-asserted-by":"crossref","first-page":"L794","DOI":"10.1152\/ajplung.00017.2022","article-title":"Pharmacological sphingosine-1 phosphate receptor 1 targeting in cigarette smoke-induced emphysema in mice","volume":"322","author":"Goel","year":"2022","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"2","key":"10.1016\/j.intimp.2025.115578_bb0030","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/bph.14861","article-title":"Functional contribution of sphingosine-1-phosphate to airway pathology in cigarette smoke-exposed mice","volume":"177","author":"De Cunto","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2025.115578_bb0035","author":"Global Initiative for Asthma"},{"issue":"3","key":"10.1016\/j.intimp.2025.115578_bb0040","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1136\/thoraxjnl-2021-218396","article-title":"Environmental risks and sphingolipid signatures in adult asthma and its phenotypic clusters: a multicentre study","volume":"78","author":"Wu","year":"2023","journal-title":"Thorax"},{"issue":"8","key":"10.1016\/j.intimp.2025.115578_bb0045","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1111\/all.14236","article-title":"Ceramide\/sphingosine-1-phosphate imbalance is associated with distinct inflammatory phenotypes of uncontrolled asthma","volume":"75","author":"Kim","year":"2020","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.intimp.2025.115578_bb0050","doi-asserted-by":"crossref","first-page":"L377","DOI":"10.1152\/ajplung.00269.2023","article-title":"Sphingosine kinase 1-specific inhibitor PF543 reduces goblet cell metaplasia of bronchial epithelium in an acute asthma model","volume":"326","author":"Sudhadevi","year":"2024","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"7","key":"10.1016\/j.intimp.2025.115578_bb0055","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/bph.14597","article-title":"Blockage of sphingosine-1-phosphate receptor 2 attenuates allergic asthma in mice","volume":"176","author":"Park","year":"2019","journal-title":"Br. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.intimp.2025.115578_bb0060","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203211","article-title":"Role of S1P\/S1PR3 axis in release of CCL20 from human bronchial epithelial cells","volume":"13","author":"Kawa","year":"2018","journal-title":"PloS One"},{"issue":"6","key":"10.1016\/j.intimp.2025.115578_bb0065","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1038\/s41385-018-0077-5","article-title":"Sphingosine 1-phosphate receptor modulator ONO-4641 stimulates CD11b(+)gr-1(+) cell expansion and inhibits lymphocyte infiltration in the lungs to ameliorate murine pulmonary emphysema","volume":"11","author":"Asakura","year":"2018","journal-title":"Mucosal Immunol."},{"issue":"10","key":"10.1016\/j.intimp.2025.115578_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14102035","article-title":"Novel dimer derivatives of PF-543 as potential antitumor agents for the treatment of non-small cell lung cancer","volume":"14","author":"Kim","year":"2022","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.intimp.2025.115578_bb0075","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/s41419-022-05049-4","article-title":"Targeting sphingosine kinase 1\/2 by a novel dual inhibitor SKI-349 suppresses non-small cell lung cancer cell growth","volume":"13","author":"Xue","year":"2022","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.intimp.2025.115578_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/ph17050582","article-title":"Evaluation of the efficacy of OSU-2S in the treatment of non-small-cell lung Cancer and screening of potential targets of action","volume":"17","author":"Han","year":"2024","journal-title":"Pharmaceuticals (Basel)"},{"issue":"15","key":"10.1016\/j.intimp.2025.115578_bb0085","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23158192","article-title":"Therapeutic potential of fingolimod and dimethyl fumarate in non-small cell lung cancer preclinical models","volume":"23","author":"Rupp","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2025.115578_bb0090","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jss.2021.03.006","article-title":"JTE-013 alleviates inflammatory injury and endothelial dysfunction induced by Sepsis in vivo and in vitro","volume":"265","author":"Xu","year":"2021","journal-title":"J. Surg. Res."},{"issue":"1","key":"10.1016\/j.intimp.2025.115578_bb0095","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1186\/s12967-024-05220-9","article-title":"S1PR3 inhibition protects against LPS-induced ARDS by inhibiting NF-\u03baB and improving mitochondrial oxidative phosphorylation","volume":"22","author":"Peng","year":"2024","journal-title":"J. Transl. Med."},{"issue":"19","key":"10.1016\/j.intimp.2025.115578_bb0100","doi-asserted-by":"crossref","first-page":"14557","DOI":"10.1021\/acs.jmedchem.1c01066","article-title":"Discovery and optimization of orally bioavailable phthalazone and cinnolone carboxylic acid derivatives as S1P2 antagonists against fibrotic diseases","volume":"64","author":"Mammoliti","year":"2021","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.intimp.2025.115578_bb0105","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.1021\/acs.jmedchem.1c00138","article-title":"Discovery of the S1P2 antagonist GLPG2938 (1-[2-ethoxy-6-(trifluoromethyl)-4-pyridyl]-3-[[5-methyl-6-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]pyridazin-3-yl]methyl]urea), a preclinical candidate for the treatment of idiopathic pulmonary fibrosis","volume":"64","author":"Mammoliti","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.intimp.2025.115578_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117123","article-title":"Thymoquinone, artemisinin, and thymol attenuate proliferation of lung cancer cells as sphingosine kinase 1 inhibitors","volume":"177","author":"Shakeel","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.intimp.2025.115578_bb0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105574","article-title":"Metabolomics and integrated network pharmacology analysis reveal Tricin as the active anti-cancer component of Weijing decoction by suppression of PRKCA and sphingolipid signaling","volume":"171","author":"Li","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"18","key":"10.1016\/j.intimp.2025.115578_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/ijms231810870","article-title":"Resveratrol affects sphingolipid metabolism in A549 lung adenocarcinoma cells","volume":"23","author":"Momchilova","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2025.115578_bb0125","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1538\/expanim.21-0160","article-title":"MicroRNA-363-3p\/sphingosine-1-phosphate receptor 1 axis inhibits sepsis-induced acute lung injury via the inactivation of nuclear factor kappa-B ligand signaling","volume":"71","author":"Meng","year":"2022","journal-title":"Exp. Anim."},{"issue":"4","key":"10.1016\/j.intimp.2025.115578_bb0130","first-page":"308","article-title":"Osthole attenuates pulmonary arterial hypertension by the regulation of sphingosine 1-phosphate in rats","volume":"18","author":"Yao","year":"2020","journal-title":"Chin. J. Nat. Med."},{"key":"10.1016\/j.intimp.2025.115578_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113341","article-title":"Sphingosine 1-phosphate receptor, a new therapeutic direction in different diseases","volume":"153","author":"Chen","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"13","key":"10.1016\/j.intimp.2025.115578_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/cells11132058","article-title":"Sphingosine-1-phosphate (S1P) and S1P signaling pathway modulators, from current insights to future perspectives","volume":"11","author":"Bravo","year":"2022","journal-title":"Cells"},{"issue":"7503","key":"10.1016\/j.intimp.2025.115578_bb0145","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nature13475","article-title":"Sphingolipid metabolites in inflammatory disease","volume":"510","author":"Maceyka","year":"2014","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.intimp.2025.115578_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.104775","article-title":"Sphingosine-1-phosphate and its receptors in vascular endothelial and lymphatic barrier function","volume":"299","author":"Weigel","year":"2023","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.intimp.2025.115578_bb0155","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1016\/j.cell.2023.04.028","article-title":"Structural and functional insights into Spns2-mediated transport of sphingosine-1-phosphate","volume":"186","author":"Chen","year":"2023","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.intimp.2025.115578_bb0160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24044018","article-title":"Dialogue between VE-cadherin and sphingosine 1 phosphate Receptor1 (S1PR1) for protecting endothelial functions","volume":"24","author":"Garnier","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2025.115578_bb0165","article-title":"How do sphingosine-1-phosphate affect immune cells to resolve inflammation?","volume":"15","author":"Sun","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115578_bb0170","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202254689","article-title":"Sphingosine-1-phosphate controls endothelial sphingolipid homeostasis via ORMDL","volume":"24","author":"Sasset","year":"2023","journal-title":"EMBO Rep."},{"issue":"10","key":"10.1016\/j.intimp.2025.115578_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2024.100631","article-title":"The sphingosine kinase 2 inhibitors ABC294640 and K145 elevate (dihydro)sphingosine 1-phosphate levels in various cells","volume":"65","author":"Prell","year":"2024","journal-title":"J. Lipid Res."},{"issue":"7677","key":"10.1016\/j.intimp.2025.115578_bb0180","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nature24053","article-title":"Mfsd2b is essential for the sphingosine-1-phosphate export in erythrocytes and platelets","volume":"550","author":"Vu","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.intimp.2025.115578_bb0185","series-title":"Assessing Spns2-dependent S1P Transport as a Prospective Therapeutic Target","author":"Kharel","year":"2024"},{"issue":"16","key":"10.1016\/j.intimp.2025.115578_bb0190","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1161\/CIRCULATIONAHA.123.064181","article-title":"Abnormal lymphatic sphingosine-1-phosphate signaling aggravates lymphatic dysfunction and tissue inflammation","volume":"148","author":"Kim","year":"2023","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.intimp.2025.115578_bb0195","first-page":"213","article-title":"Sphingosine 1-phosphate and its regulatory role in vascular endothelial cells","volume":"37","author":"Qiu","year":"2022","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.intimp.2025.115578_bb0200","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.cca.2021.03.025","article-title":"Sphingosine-1-phosphate receptor 3 signaling","volume":"519","author":"Li","year":"2021","journal-title":"Clin. Chim. Acta"},{"issue":"9","key":"10.1016\/j.intimp.2025.115578_bb0205","article-title":"Post-translational modifications of S1PR1 and endothelial barrier regulation","volume":"1865","author":"Anwar","year":"2020","journal-title":"Biochim. Biophys. Acta Mol. Cell Biol. Lipids"},{"issue":"5","key":"10.1016\/j.intimp.2025.115578_bb0210","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1002\/med.22044","article-title":"An overview of sphingosine-1-phosphate receptor 2: structure, biological function, and small-molecule modulators","volume":"44","author":"Hao","year":"2024","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.intimp.2025.115578_bb0215","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1427509","article-title":"Sphingosine-1-phosphate receptor 4 links neutrophils and early local inflammation to lymphocyte recruitment into the draining lymph node to facilitate robust germinal center formation","volume":"15","author":"Luker","year":"2024","journal-title":"Front. Immunol."},{"issue":"22","key":"10.1016\/j.intimp.2025.115578_bb0220","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232213892","article-title":"The crosstalk between Fc\u03b5RI and sphingosine signaling in allergic inflammation","volume":"23","author":"Jo","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3.4","key":"10.1016\/j.intimp.2025.115578_bb0225","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2152\/jmi.69.196","article-title":"Lysophosphatidic acid, ceramide 1-phosphate and sphingosine 1-phosphate in peripheral blood of patients with idiopathic pulmonary fibrosis","volume":"69","author":"Tanaka","year":"2022","journal-title":"J. Med. Invest."},{"issue":"3","key":"10.1016\/j.intimp.2025.115578_bb0230","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.apsb.2022.10.006","article-title":"S1PR1 serves as a viable drug target against pulmonary fibrosis by increasing the integrity of the endothelial barrier of the lung","volume":"13","author":"Hao","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.intimp.2025.115578_bb0235","doi-asserted-by":"crossref","unstructured":"Sudhadevi T, Annadi A, Basa P, Jafri A, Natarajan V, Harijith A. Fingolimod, a sphingosine-1-phosphate receptor modulator, prevents neonatal bronchopulmonary dysplasia and subsequent airway remodeling in a murine model. J. Appl. Physiol. (1985). 2024;137(5):1231\u20131242.","DOI":"10.1152\/japplphysiol.00311.2024"},{"issue":"8","key":"10.1016\/j.intimp.2025.115578_bb0250","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1111\/bph.15754","article-title":"Sphingosine-1-phosphate\/TGF-\u03b2 axis drives epithelial mesenchymal transition in asthma-like disease","volume":"179","author":"Riemma","year":"2022","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2025.115578_bb0255","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.molimm.2020.09.020","article-title":"Activation of AMPK suppresses S1P-induced airway smooth muscle cells proliferation and its potential mechanisms","volume":"128","author":"Pan","year":"2020","journal-title":"Mol. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2025.115578_bb0260","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.7150\/ijbs.80256","article-title":"Sphingosine-1-phosphate receptor 4 attenuates neutrophilic airway inflammation in experimental asthma via repressing proinflammatory macrophage activation","volume":"19","author":"Wang","year":"2023","journal-title":"Int. J. Biol. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2025.115578_bb0265","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23266","article-title":"Fingolimod attenuates ovalbumin-induced airway inflammation via inhibiting MAPK\/ERK signaling in mice","volume":"37","author":"Makled","year":"2023","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"2","key":"10.1016\/j.intimp.2025.115578_bb0290","doi-asserted-by":"crossref","first-page":"259","DOI":"10.17305\/bjbms.2022.8034","article-title":"Deletion of sphingosine kinase 2 attenuates cigarette smoke-mediated chronic obstructive pulmonary disease-like symptoms by reducing lung inflammation","volume":"23","author":"Chen","year":"2023","journal-title":"Biomol. Biomed."},{"issue":"21","key":"10.1016\/j.intimp.2025.115578_bb0330","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232112741","article-title":"Targeting SPHK1\/PBX1 Axis induced cell cycle arrest in non-small cell lung cancer","volume":"23","author":"Lin","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2025.115578_bb0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.crphar.2024.100212","article-title":"The suppression of the SPHK1\/S1P\/S1PR3 signaling pathway diminishes EGFR activation and increases the sensitivity of non-small cell lung cancer to gefitinib","volume":"8","author":"Zhang","year":"2025","journal-title":"Curr. Res. Pharmacol. Drug Discov."},{"issue":"3","key":"10.1016\/j.intimp.2025.115578_bb0345","doi-asserted-by":"crossref","first-page":"725","DOI":"10.31557\/APJCP.2024.25.3.725","article-title":"A crosstalk between the receptor tyrosine kinase-like orphan receptors ROR1\/2 and S1P signaling pathways in lung cancer","volume":"25","author":"Nema","year":"2024","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"2","key":"10.1016\/j.intimp.2025.115578_bb0370","first-page":"565","article-title":"Combination treatment of FTY720 and cisplatin exhibits enhanced antitumour effects on cisplatin-resistant non-small lung cancer cells","volume":"39","author":"Li","year":"2018","journal-title":"Oncol. Rep."},{"issue":"6","key":"10.1016\/j.intimp.2025.115578_bb0425","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21062064","article-title":"Sphingosine kinase 1\/S1P signaling contributes to pulmonary fibrosis by activating hippo\/YAP pathway and mitochondrial reactive oxygen species in lung fibroblasts","volume":"21","author":"Huang","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2025.115578_bb0470","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4062\/biomolther.2018.131","article-title":"Deficiency of sphingosine-1-phosphate receptor 2 (S1P(2)) attenuates bleomycin-induced pulmonary fibrosis","volume":"27","author":"Park","year":"2019","journal-title":"Biomol. Ther. (Seoul)"},{"issue":"1","key":"10.1016\/j.intimp.2025.115578_bb0480","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/mi.2017.37","article-title":"A sphingosine-1-phosphate receptor 1 agonist inhibits tertiary lymphoid tissue reactivation and hypersensitivity in the lung","volume":"11","author":"Hupp\u00e9","year":"2018","journal-title":"Mucosal Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2025.115578_bb0490","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1165\/rcmb.2019-0339OC","article-title":"S1P(1) contributes to endotoxin-enhanced B-cell functions involved in hypersensitivity pneumonitis","volume":"63","author":"Hupp\u00e9","year":"2020","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115578_bb0585","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41420-023-01320-5","article-title":"Nuclear SPHK2\/S1P induces oxidative stress and NLRP3 inflammasome activation via promoting p53 acetylation in lipopolysaccharide-induced acute lung injury","volume":"9","author":"Gong","year":"2023","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.intimp.2025.115578_bb0630","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.intimp.2018.06.036","article-title":"Transcriptomic analysis of lung tissues after hUC-MSCs and FTY720 treatment of lipopolysaccharide-induced acute lung injury in mouse models","volume":"63","author":"Huang","year":"2018","journal-title":"Int. Immunopharmacol."},{"issue":"22","key":"10.1016\/j.intimp.2025.115578_bb0605","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242216083","article-title":"Sphingosine-1-phosphate receptor 3 induces endothelial barrier loss via ADAM10-mediated vascular endothelial-cadherin cleavage","volume":"24","author":"Wu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2025.115578_bb0595","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2022.112074","article-title":"S1P lyase inhibition prevents lung injury following high pressure-controlled mechanical ventilation in aging mice","volume":"173","author":"Valentine","year":"2023","journal-title":"Exp. Gerontol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115578_bb0570","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19010114","article-title":"Sphingolipids in ventilator induced lung injury: role of sphingosine-1-phosphate lyase","volume":"19","author":"Suryadevara","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.intimp.2025.115578_bib1016","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1007\/s10753-021-01490-3","article-title":"Blocking SphK1\/S1P\/S1PR1 Signaling Pathway Alleviates Lung Injury Caused by Sepsis in Acute Ethanol Intoxication Mice","volume":"44","author":"Chen","year":"2021","journal-title":"Inflammation"},{"issue":"8","key":"10.1016\/j.intimp.2025.115578_bib1017","doi-asserted-by":"crossref","DOI":"10.1177\/03000605211032806","article-title":"Fingolimod attenuates renal ischemia\/reperfusion-induced acute lung injury by inhibiting inflammation and apoptosis and modulating S1P metabolism","volume":"49","author":"Shi","year":"2021","journal-title":"J. Int. Med. Res."},{"issue":"1","key":"10.1016\/j.intimp.2025.115578_bb0625","doi-asserted-by":"crossref","first-page":"L149","DOI":"10.1152\/ajplung.00100.2021","article-title":"MRSA-induced endothelial permeability and acute lung injury are attenuated by FTY720 S-phosphonate","volume":"322","author":"Wang","year":"2022","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.intimp.2025.115578_bb0655","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.crimmu.2022.05.004","article-title":"Sphingosine-1-phosphate receptors 2 and 3 reprogram resting human macrophages into M1 phenotype following mycobacteria infection","volume":"3","author":"Arish","year":"2022","journal-title":"Curr. Res. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2025.115578_bb0675","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1038\/s41385-018-0065-9","article-title":"Pulmonary immunization with a recombinant influenza a virus vaccine induces lung-resident CD4(+) memory T cells that are associated with protection against tuberculosis","volume":"11","author":"Fl\u00f3rido","year":"2018","journal-title":"Mucosal Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2025.115578_bib1018","doi-asserted-by":"crossref","first-page":"e00601","DOI":"10.1128\/IAI.00601-18","article-title":"Peptidoglycan Recognition Protein 4 Suppresses Early Inflammatory Responses to Bordetella pertussis and Contributes to Sphingosine-1-Phosphate Receptor Agonist-Mediated Disease Attenuation","volume":"87","author":"Skerry","year":"2019","journal-title":"Infect. Immun."},{"issue":"6","key":"10.1016\/j.intimp.2025.115578_bb0745","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.cell.2011.08.015","article-title":"Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection","volume":"146","author":"Teijaro","year":"2011","journal-title":"Cell"},{"issue":"29","key":"10.1016\/j.intimp.2025.115578_bb0750","doi-asserted-by":"crossref","first-page":"12018","DOI":"10.1073\/pnas.1107024108","article-title":"Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus","volume":"108","author":"Walsh","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.intimp.2025.115578_bb0825","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.chest.2023.10.023","article-title":"Ozanimod therapy in patients with COVID-19 requiring oxygen support: a randomized open-label pilot trial","volume":"165","author":"Lellouche","year":"2024","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.intimp.2025.115578_bb0830","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.1039","article-title":"The effect of fingolimod on patients with moderate to severe COVID-19","volume":"11","author":"Teymouri","year":"2023","journal-title":"Pharmacol. Res. Perspect."},{"issue":"9","key":"10.1016\/j.intimp.2025.115578_bb0895","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1136\/jnnp-2022-329395","article-title":"SARS-CoV-2 mRNA vaccinations fail to elicit humoral and cellular immune responses in patients with multiple sclerosis receiving fingolimod","volume":"93","author":"Meyer-Arndt","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"14","key":"10.1016\/j.intimp.2025.115578_bb0905","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1177\/13524585231200719","article-title":"Differential effects of selective versus unselective sphingosine 1-phosphate receptor modulators on T- and B-cell response to SARS-CoV-2 vaccination","volume":"29","author":"Proschmann","year":"2023","journal-title":"Mult. Scler."},{"key":"10.1016\/j.intimp.2025.115578_bb0970","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.lfs.2018.08.071","article-title":"Resveratrol inhibits monocrotaline-induced pulmonary arterial remodeling by suppression of SphK1-mediated NF-\u03baB activation","volume":"210","author":"Shi","year":"2018","journal-title":"Life Sci."},{"issue":"8","key":"10.1016\/j.intimp.2025.115578_bb0985","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1161\/CIRCRESAHA.123.322740","article-title":"Altered smooth muscle cell histone acetylome by the SPHK2\/S1P axis promotes pulmonary hypertension","volume":"133","author":"Ranasinghe","year":"2023","journal-title":"Circ. Res."},{"issue":"3","key":"10.1016\/j.intimp.2025.115578_bb1000","doi-asserted-by":"crossref","first-page":"L497","DOI":"10.1152\/ajplung.00169.2020","article-title":"Neonatal therapy with PF543, a sphingosine kinase 1 inhibitor, ameliorates hyperoxia-induced airway remodeling in a murine model of bronchopulmonary dysplasia","volume":"319","author":"Ha","year":"2020","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"5","key":"10.1016\/j.intimp.2025.115578_bb0240","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.jaci.2023.05.028","article-title":"Sphingosine-1-phosphate induces airway smooth muscle hyperresponsiveness and proliferation","volume":"152","author":"Maguire","year":"2023","journal-title":"J. Allergy Clin. Immunol."},{"issue":"3\u20134","key":"10.1016\/j.intimp.2025.115578_bb0245","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00335-018-9743-x","article-title":"Loss of the zona pellucida-binding protein 2 (Zpbp2) gene in mice impacts airway hypersensitivity and lung lipid metabolism in a sex-dependent fashion","volume":"29","author":"Kanagaratham","year":"2018","journal-title":"Mamm. Genome"},{"issue":"3","key":"10.1016\/j.intimp.2025.115578_bb0270","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202201821R","article-title":"Neutrophilia in severe asthma is reduced in Ormdl3 overexpressing mice","volume":"37","author":"James","year":"2023","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.intimp.2025.115578_bb0275","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00761-2019","article-title":"The role of the 17q21 genotype in the prevention of early childhood asthma and recurrent wheeze by vitamin D","volume":"54","author":"Kelly","year":"2019","journal-title":"Eur. Respir. J."},{"issue":"8","key":"10.1016\/j.intimp.2025.115578_bb0280","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S2213-2600(24)00339-4","article-title":"The global burden of COPD: epidemiology and effect of prevention strategies","volume":"13","author":"de Oca","year":"2025","journal-title":"Lancet Respir. Med."},{"issue":"2","key":"10.1016\/j.intimp.2025.115578_bb0285","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00948-2023","article-title":"Postural balance in COPD with obstructive sleep apnoea: a cross-sectional study","volume":"10","author":"de Censo","year":"2024","journal-title":"ERJ Open Res."},{"issue":"4","key":"10.1016\/j.intimp.2025.115578_bb0295","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.arcmed.2023.03.005","article-title":"S1PR2 is important for cigarette smoke-induced pyroptosis in human bronchial epithelial cells","volume":"54","author":"Xu","year":"2023","journal-title":"Arch. Med. Res."},{"issue":"9","key":"10.1016\/j.intimp.2025.115578_bb0300","first-page":"4478","article-title":"Macrophage polarization involved the inflammation of chronic obstructive pulmonary disease by S1P\/HDAC1 signaling","volume":"13","author":"Zhang","year":"2023","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.intimp.2025.115578_bb0305","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2019.113078","article-title":"Metabolic profiling of chronic obstructive pulmonary disease model rats and the interventional effects of HuaTanJiangQi decoction using UHPLC-Q-TOF\/MS(E)","volume":"180","author":"Fang","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"9","key":"10.1016\/j.intimp.2025.115578_bb0310","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41571-023-00798-3","article-title":"The global burden of lung cancer: current status and future trends","volume":"20","author":"Leiter","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.intimp.2025.115578_bb0315","doi-asserted-by":"crossref","first-page":"1091825","DOI":"10.3389\/fcimb.2023.1091825","article-title":"Combined analysis of gut microbiome and serum metabolomics reveals novel biomarkers in patients with early-stage non-small cell lung cancer","volume":"13","author":"Ni","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.intimp.2025.115578_bb0320","article-title":"Anti-ceramide antibody and sphingosine-1-phosphate as potential biomarkers of unresectable non-small cell lung cancer","volume":"30","author":"B\u0171di","year":"2024","journal-title":"Pathol. Oncol. Res."},{"issue":"5","key":"10.1016\/j.intimp.2025.115578_bb0325","doi-asserted-by":"crossref","first-page":"674","DOI":"10.21037\/tlcr.2019.10.04","article-title":"Prognostic roles of the expression of sphingosine-1-phosphate metabolism enzymes in non-small cell lung cancer","volume":"8","author":"Wang","year":"2019","journal-title":"Transl. Lung Cancer Res."},{"issue":"2","key":"10.1016\/j.intimp.2025.115578_bb0340","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.bbrc.2018.05.029","article-title":"Apolipoprotein M promotes proliferation and invasion in non-small cell lung cancers via upregulating S1PR1 and activating the ERK1\/2 and PI3K\/AKT signaling pathways","volume":"501","author":"Zhu","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.intimp.2025.115578_bb0350","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.freeradbiomed.2022.07.001","article-title":"miR-495-3p regulates sphingolipid metabolic reprogramming to induce Sphk1\/ceramide mediated mitophagy and apoptosis in NSCLC","volume":"189","author":"Arora","year":"2022","journal-title":"Free Radic. Biol. Med."},{"issue":"16","key":"10.1016\/j.intimp.2025.115578_bb0355","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.4103\/0366-6999.238135","article-title":"MiR-125b-1-3p exerts antitumor functions in lung carcinoma cells by targeting S1PR1","volume":"131","author":"Zhang","year":"2018","journal-title":"Chin. Med. J. (Engl.)"},{"issue":"11","key":"10.1016\/j.intimp.2025.115578_bb0360","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/s41419-020-03146-w","article-title":"GDC-0349 inhibits non-small cell lung cancer cell growth","volume":"11","author":"Yang","year":"2020","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.intimp.2025.115578_bb0365","first-page":"1259","article-title":"Sphingosine kinase-1 predicts overall survival outcomes in non-small cell lung cancer patients treated with carboplatin and navelbine","volume":"18","author":"Gachechiladze","year":"2019","journal-title":"Oncol. Lett."},{"issue":"5","key":"10.1016\/j.intimp.2025.115578_bb0375","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2021.5037","article-title":"SPHK1 contributes to cisplatin resistance in bladder cancer cells via the NONO\/STAT3 axis","volume":"48","author":"Qin","year":"2021","journal-title":"Int. J. Mol. Med."},{"issue":"16","key":"10.1016\/j.intimp.2025.115578_bb0380","doi-asserted-by":"crossref","DOI":"10.3390\/cells11162524","article-title":"S1P-induced TNF-\u03b1 and IL-6 release from PBMCs exacerbates lung cancer-associated inflammation","volume":"11","author":"Terlizzi","year":"2022","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.intimp.2025.115578_bb0385","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001054","article-title":"Natural killer cells in the human lung tumor microenvironment display immune inhibitory functions","volume":"8","author":"Russick","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"2","key":"10.1016\/j.intimp.2025.115578_bb0390","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1158\/2326-6066.CIR-23-0221","article-title":"Tumor-derived RAB21+ABHD12+ sEVs drive the premetastatic microenvironment in the lung","volume":"12","author":"Wu","year":"2024","journal-title":"Cancer Immunol. Res."},{"issue":"13","key":"10.1016\/j.intimp.2025.115578_bb0395","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241310841","article-title":"Sex differences in sphingosine-1-phosphate levels are dependent on ceramide synthase 1 and ceramidase in lung physiology and tumor conditions","volume":"24","author":"Terlizzi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.intimp.2025.115578_bb0400","doi-asserted-by":"crossref","first-page":"539","DOI":"10.33594\/000000431","article-title":"Intracellular sphingosine-1-phosphate receptor 3 contributes to lung tumor cell proliferation","volume":"55","author":"Terlizzi","year":"2021","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.intimp.2025.115578_bb0405","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2020.104141","article-title":"Prognostic role of lipid phosphate phosphatases in non-smoker, lung adenocarcinoma patients","volume":"129","author":"Nema","year":"2021","journal-title":"Comput. Biol. Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.115578_bb0410","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s13046-024-03230-5","article-title":"S1PR1 suppresses lung adenocarcinoma progression through p-STAT1\/miR-30c-5 p\/FOXA1 pathway","volume":"43","author":"Chai","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.intimp.2025.115578_bb0415","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2213-2600(25)00129-8","article-title":"Global epidemiology and burden of interstitial lung disease","volume":"13","author":"Spagnolo","year":"2025","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.intimp.2025.115578_bb0420","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.122272","article-title":"Trigonelline mitigates bleomycin-induced pulmonary inflammation and fibrosis: insight into NLRP3 inflammasome and SPHK1\/S1P\/hippo signaling modulation","volume":"336","author":"Zeyada","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2025.115578_bb0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2023.102228","article-title":"S1PR1 attenuates pulmonary fibrosis by inhibiting EndMT and improving endothelial barrier function","volume":"81","author":"Xiong","year":"2023","journal-title":"Pulm. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2025.115578_bb0435","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1165\/rcmb.2020-0408OC","article-title":"Endothelial-specific loss of sphingosine-1-phosphate receptor 1 increases vascular permeability and exacerbates bleomycin-induced pulmonary fibrosis","volume":"66","author":"Knipe","year":"2022","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"5","key":"10.1016\/j.intimp.2025.115578_bb0440","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197604","article-title":"Sphingosine-1-phosphate receptor-2 facilitates pulmonary fibrosis through potentiating IL-13 pathway in macrophages","volume":"13","author":"Zhao","year":"2018","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.intimp.2025.115578_bb0445","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1002\/jcp.29138","article-title":"S1PR3 deficiency alleviates radiation-induced pulmonary fibrosis through the regulation of epithelial-mesenchymal transition by targeting miR-495-3p","volume":"235","author":"Gong","year":"2020","journal-title":"J. Cell. Physiol."},{"issue":"6","key":"10.1016\/j.intimp.2025.115578_bb0450","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1139\/bcb-2017-0302","article-title":"Quercetin ameliorates pulmonary fibrosis by inhibiting SphK1\/S1P signaling","volume":"96","author":"Zhang","year":"2018","journal-title":"Biochem. Cell Biol."},{"issue":"16","key":"10.1016\/j.intimp.2025.115578_bb0455","doi-asserted-by":"crossref","first-page":"15354","DOI":"10.1021\/acsnano.2c10388","article-title":"Pulmonary delivery of specialized pro-resolving mediators-based nanotherapeutics attenuates pulmonary fibrosis in preclinical animal models","volume":"17","author":"Li","year":"2023","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.intimp.2025.115578_bb0460","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/path.6256","article-title":"Gene therapy with AAV9-SGPL1 in an animal model of lung fibrosis","volume":"263","author":"Bhattacharyya","year":"2024","journal-title":"J. Pathol."},{"issue":"2","key":"10.1016\/j.intimp.2025.115578_bb0465","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1165\/rcmb.2023-0286OC","article-title":"Augmentation of endothelial S1PR1 attenuates postviral pulmonary fibrosis","volume":"70","author":"Brazee","year":"2024","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"6","key":"10.1016\/j.intimp.2025.115578_bb0475","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1165\/rcmb.2009-0345OC","article-title":"Prolonged exposure to sphingosine 1-phosphate receptor-1 agonists exacerbates vascular leak, fibrosis, and mortality after lung injury","volume":"43","author":"Shea","year":"2010","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"10","key":"10.1016\/j.intimp.2025.115578_bb0485","article-title":"Fibrotic hypersensitivity pneumonitis: a diagnostic challenge leading to lung transplantation","volume":"15","author":"Mot","year":"2025","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"10.1016\/j.intimp.2025.115578_bb0495","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s12931-022-02200-9","article-title":"Co-modulation of T cells and B cells enhances the inhibition of inflammation in experimental hypersensitivity pneumonitis","volume":"23","author":"Courtemanche","year":"2022","journal-title":"Respir. Res."},{"key":"10.1016\/j.intimp.2025.115578_bb0500","article-title":"Global burden of pneumoconiosis attributable to occupational particulate matter, gasses, and fumes from 1990\u223c2021 and forecasting the future trends: a population-based study","volume":"12","author":"Qingsong","year":"2024","journal-title":"Front. Public Health"},{"issue":"1\u20132","key":"10.1016\/j.intimp.2025.115578_bb0505","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11010-020-03706-w","article-title":"Evaluation of oxysterol levels of patients with silicosis by LC-MS\/MS method","volume":"467","author":"Aksu","year":"2020","journal-title":"Mol. Cell. Biochem."},{"issue":"9","key":"10.1016\/j.intimp.2025.115578_bb0510","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1002\/jat.4467","article-title":"SiO(2) dust induces inflammation and pulmonary fibrosis in rat lungs through activation of ASMase\/ceramide pathway","volume":"43","author":"Huang","year":"2023","journal-title":"J. Appl. Toxicol."},{"issue":"10","key":"10.1016\/j.intimp.2025.115578_bb0515","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1002\/jat.4148","article-title":"SiO(2) stimulates macrophage stress to induce the transformation of lung fibroblasts into myofibroblasts and its relationship with the sphingomyelin metabolic pathway","volume":"41","author":"Liu","year":"2021","journal-title":"J. Appl. Toxicol."},{"issue":"2","key":"10.1016\/j.intimp.2025.115578_bb0520","first-page":"155","article-title":"The evolution of diastolic function during liver transplantation","volume":"37","author":"Devauchelle","year":"2018","journal-title":"Anaesth. Crit. Care Pain Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.115578_bb0525","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s13054-024-05000-3","article-title":"Integrative multi-omics analysis unravels the host response landscape and reveals a serum protein panel for early prognosis prediction for ARDS","volume":"28","author":"Lin","year":"2024","journal-title":"Crit. Care"},{"issue":"9","key":"10.1016\/j.intimp.2025.115578_bb0530","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222098","article-title":"Expression of sphingosine kinase 1 and sphingosine 1-phosphate receptor 3 in malaria-associated acute lung injury\/acute respiratory distress syndrome in a mouse model","volume":"14","author":"Punsawad","year":"2019","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.intimp.2025.115578_bb0535","doi-asserted-by":"crossref","first-page":"L589","DOI":"10.1152\/ajplung.00388.2023","article-title":"Preservation of recipient plasma sphingosine-1-phosphate levels reduces transfusion-related acute lung injury","volume":"326","author":"Hsing","year":"2024","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.intimp.2025.115578_bb0540","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2020.105819","article-title":"HDL-S1P protects endothelial function and reduces lung injury during sepsis in vivo and in vitro","volume":"126","author":"Fan","year":"2020","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"5","key":"10.1016\/j.intimp.2025.115578_bb0545","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1182\/blood.2020005985","article-title":"Platelet extracellular vesicles mediate transfusion-related acute lung injury by imbalancing the sphingolipid rheostat","volume":"137","author":"McVey","year":"2021","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.intimp.2025.115578_bb0550","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/SHK.0000000000001618","article-title":"Remote ischemic conditioning reduced acute lung injury after traumatic brain injury in the mouse","volume":"55","author":"Saber","year":"2021","journal-title":"Shock"},{"issue":"12","key":"10.1016\/j.intimp.2025.115578_bb0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2022.166562","article-title":"TLR4 activation induces inflammatory vascular permeability via Dock1 targeting and NOX4 upregulation","volume":"1868","author":"Song","year":"2022","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"issue":"3","key":"10.1016\/j.intimp.2025.115578_bb0560","doi-asserted-by":"crossref","first-page":"e258","DOI":"10.1097\/CCM.0000000000002916","article-title":"Sphingosine kinase 1 regulates inflammation and contributes to acute lung injury in pneumococcal pneumonia via the sphingosine-1-phosphate receptor 2","volume":"46","author":"Gutbier","year":"2018","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.intimp.2025.115578_bb0565","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.110868","article-title":"Inhibition of sphingosine kinase 1 attenuates LPS-induced acute lung injury by suppressing endothelial cell pyroptosis","volume":"390","author":"Li","year":"2024","journal-title":"Chem. Biol. Interact."},{"issue":"6","key":"10.1016\/j.intimp.2025.115578_bb0575","first-page":"2077","article-title":"Upregulation of sphingosine kinase 1 contributes to ventilator-associated lung injury in a two-hit model","volume":"44","author":"Wang","year":"2019","journal-title":"Int. J. Mol. Med."},{"issue":"1","key":"10.1016\/j.intimp.2025.115578_bb0580","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/thoraxjnl-2020-216469","article-title":"Sphingosine kinase 1 regulates lysyl oxidase through STAT3 in hyperoxia-mediated neonatal lung injury","volume":"77","author":"Ha","year":"2022","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.intimp.2025.115578_bb0590","first-page":"47","article-title":"S1P generation by sphingosine Kinase-2 in recruited macrophages resolves lung inflammation by blocking STING signaling in alveolar macrophages","volume":"2","author":"Joshi","year":"2021","journal-title":"J. Cell Signal."},{"issue":"2","key":"10.1016\/j.intimp.2025.115578_bb0600","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/CIRCRESAHA.120.318412","article-title":"Programming to S1PR1(+) endothelial cells promotes restoration of vascular integrity","volume":"129","author":"Akhter","year":"2021","journal-title":"Circ. Res."},{"issue":"12","key":"10.1016\/j.intimp.2025.115578_bb0610","first-page":"1815","article-title":"Knockout of S1PR3 attenuates acute lung injury in mice by inhibiting the MAPK pathway","volume":"42","author":"Fang","year":"2022","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"issue":"3","key":"10.1016\/j.intimp.2025.115578_bb0615","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1165\/rcmb.2023-0075OC","article-title":"Lack of S1PR2 in macrophage ameliorates sepsis-associated lung injury through inducing IL-33-mediated type 2 immunity","volume":"70","author":"Gong","year":"2024","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115578_bb0620","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/1566523220666201230100523","article-title":"TGF-\u03b21-based CRISPR\/Cas9 gene therapy attenuates radiation-induced lung injury","volume":"22","author":"Zhen","year":"2022","journal-title":"Curr. Gene Ther."},{"issue":"1","key":"10.1016\/j.intimp.2025.115578_bb0635","doi-asserted-by":"crossref","DOI":"10.1177\/2045894020905521","article-title":"Sphingosine-1-phosphate receptor-independent lung endothelial cell barrier disruption induced by FTY720 regioisomers","volume":"10","author":"Camp","year":"2020","journal-title":"Pulm. Circ."},{"issue":"2","key":"10.1016\/j.intimp.2025.115578_bb0640","doi-asserted-by":"crossref","first-page":"191","DOI":"10.15283\/ijsc23001","article-title":"Cyclic phytosphingosine-1-phosphate primed mesenchymal stem cells ameliorate LPS-induced acute lung injury in mice","volume":"16","author":"Park","year":"2023","journal-title":"Int. J. Stem Cells"},{"key":"10.1016\/j.intimp.2025.115578_bb0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.111085","article-title":"Kaempferol mitigates sepsis-induced acute lung injury by modulating the SphK1\/S1P\/S1PR1\/MLC2 signaling pathway to restore the integrity of the pulmonary endothelial cell barrier","volume":"398","author":"Gao","year":"2024","journal-title":"Chem. Biol. Interact."},{"issue":"2","key":"10.1016\/j.intimp.2025.115578_bb0650","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.111878","article-title":"RGS2 is an innate immune checkpoint for suppressing G\u03b1q-mediated IFN\u03b3 generation and lung injury","volume":"28","author":"Joshi","year":"2025","journal-title":"iScience"},{"key":"10.1016\/j.intimp.2025.115578_bb0660","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2024.107325","article-title":"Insights from the 2024 WHO global tuberculosis report \u2013 more comprehensive action, innovation, and investments required for achieving WHO end TB goals","volume":"150","author":"Goletti","year":"2025","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.intimp.2025.115578_bb0665","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.3389\/fimmu.2019.03085","article-title":"Sphingosine-1-phosphate (S-1P) promotes differentiation of naive macrophages and enhances protective immunity against mycobacterium tuberculosis","volume":"10","author":"Nadella","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115578_bb0670","article-title":"Molecular indicator for distinguishing multi-drug-resistant tuberculosis from drug sensitivity tuberculosis and potential medications for treatment","author":"Song","year":"2024","journal-title":"Mol. Biotechnol."},{"issue":"6","key":"10.1016\/j.intimp.2025.115578_bb0680","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/thoraxjnl-2018-212378","article-title":"Pseudomonas aeruginosa stimulates nuclear sphingosine-1-phosphate generation and epigenetic regulation of lung inflammatory injury","volume":"74","author":"Ebenezer","year":"2019","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.intimp.2025.115578_bb0685","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00097-20","article-title":"Collaborative cross mice yield genetic modifiers for Pseudomonas aeruginosa infection in human lung disease","volume":"11","author":"Lor\u00e8","year":"2020","journal-title":"mBio"},{"issue":"10","key":"10.1016\/j.intimp.2025.115578_bb0690","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00126-21","article-title":"Triggering receptor expressed on myeloid cells-1 (TREM-1) contributes to Bordetella pertussis inflammatory pathology","volume":"89","author":"Gallop","year":"2021","journal-title":"Infect. Immun."},{"issue":"2","key":"10.1016\/j.intimp.2025.115578_bb0695","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00601-18","article-title":"Peptidoglycan recognition protein 4 suppresses early inflammatory responses to Bordetella pertussis and contributes to sphingosine-1-phosphate receptor agonist-mediated disease attenuation","volume":"87","author":"Skerry","year":"2019","journal-title":"Infect. Immun."},{"issue":"12","key":"10.1016\/j.intimp.2025.115578_bb0700","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202101247","article-title":"Non-canonical activation of the ER stress sensor ATF6 by Legionella pneumophila effectors","volume":"4","author":"Ibe","year":"2021","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.intimp.2025.115578_bb0705","series-title":"Pandemic and seasonal influenza severity assessment guidance updated. [Online]","author":"World Health Organization","year":"2024"},{"issue":"6","key":"10.1016\/j.intimp.2025.115578_bb0710","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11306-022-01898-4","article-title":"Bioactive lipid screening during respiratory tract infections with bacterial and viral pathogens in mice","volume":"18","author":"Schultz","year":"2022","journal-title":"Metabolomics"},{"issue":"9","key":"10.1016\/j.intimp.2025.115578_bb0715","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010794","article-title":"Enzymatic independent role of sphingosine kinase 2 in regulating the expression of type I interferon during influenza A virus infection","volume":"18","author":"Xu","year":"2022","journal-title":"PLoS Pathog."},{"issue":"4","key":"10.1016\/j.intimp.2025.115578_bb0720","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1089\/dna.2022.0071","article-title":"Analyzing opposing interactions between sphingosine 1-phosphate lyase and influenza a virus","volume":"41","author":"Wolf","year":"2022","journal-title":"DNA Cell Biol."},{"issue":"20","key":"10.1016\/j.intimp.2025.115578_bb0725","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1097\/CM9.0000000000001036","article-title":"Down-regulation of miR-155 inhibits inflammatory response in human pulmonary microvascular endothelial cells infected with influenza A virus by targeting sphingosine-1-phosphate receptor 1","volume":"133","author":"Shen","year":"2020","journal-title":"Chin. Med. J. (Engl.)"},{"issue":"10","key":"10.1016\/j.intimp.2025.115578_bb0730","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205344","article-title":"Inhibition of autophagy and chemokine induction by sphingosine 1-phosphate receptor 1 through NF-\u03baB signaling in human pulmonary endothelial cells infected with influenza A viruses","volume":"13","author":"Wang","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.intimp.2025.115578_bb0735","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.virol.2021.02.006","article-title":"Influenza A virus NS1 induces degradation of sphingosine 1-phosphate lyase to obstruct the host innate immune response","volume":"558","author":"Wolf","year":"2021","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.intimp.2025.115578_bb0740","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1021\/acsinfecdis.2c00416","article-title":"Sphingosine kinases promote Ebola virus infection and can be targeted to inhibit filoviruses, coronaviruses, and arenaviruses using late endocytic trafficking to enter cells","volume":"9","author":"Stewart","year":"2023","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.intimp.2025.115578_bb0755","unstructured":"WorldHealth Organization. COVID-19 Cases WHO COVID-19 Dashboard. [Online]. World Health Organization. 2025. Available online:https:\/\/data.who.int\/dashboards\/covid19\/cases?n=o (accessed on 16 August 2025)."},{"issue":"15","key":"10.1016\/j.intimp.2025.115578_bb0760","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25158155","article-title":"Comprehensive review of COVID-19: epidemiology, pathogenesis, advancement in diagnostic and detection techniques, and post-pandemic treatment strategies","volume":"25","author":"Chung","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2025.115578_bb0765","doi-asserted-by":"crossref","DOI":"10.3390\/biom14030296","article-title":"Association of altered plasma lipidome with disease severity in COVID-19 patients","volume":"14","author":"Zhang","year":"2024","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.intimp.2025.115578_bb0770","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11306-024-02195-y","article-title":"Untargeted metabolomics and lipidomics in COVID-19 patient plasma reveals disease severity biomarkers","volume":"21","author":"Sun","year":"2024","journal-title":"Metabolomics"},{"issue":"14","key":"10.1016\/j.intimp.2025.115578_bb0775","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202401099R","article-title":"Comprehensive metabolic modulations of sphingolipids are promising severity indicators in COVID-19","volume":"38","author":"Uranbileg","year":"2024","journal-title":"FASEB J."},{"issue":"19","key":"10.1016\/j.intimp.2025.115578_bb0780","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910198","article-title":"Severity of COVID-19 patients predicted by serum sphingolipids signature","volume":"22","author":"Torretta","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2025.115578_bb0785","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2024.115732","article-title":"High-resolution targeted mass spectrometry for comprehensive quantification of sphingolipids: clinical applications and characterization of extracellular vesicles","volume":"698","author":"Felippe","year":"2025","journal-title":"Anal. Biochem."},{"issue":"1","key":"10.1016\/j.intimp.2025.115578_bb0790","first-page":"32","article-title":"Characterization of oral and gut microbiome and plasma metabolomics in COVID-19 patients after 1-year follow-up","volume":"9","author":"Cui","year":"2022","journal-title":"Mil. Med. Res."},{"issue":"1","key":"10.1016\/j.intimp.2025.115578_bb0795","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202013424","article-title":"Decreased serum level of sphingosine-1-phosphate: a novel predictor of clinical severity in COVID-19","volume":"13","author":"Marfia","year":"2021","journal-title":"EMBO Mol. Med."},{"issue":"24","key":"10.1016\/j.intimp.2025.115578_bb0800","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1042\/CS20210666","article-title":"Erythrocytes increase endogenous sphingosine 1-phosphate levels as an adaptive response to SARS-CoV-2 infection","volume":"135","author":"Winkler","year":"2021","journal-title":"Clin. Sci. (Lond.)"},{"issue":"17","key":"10.1016\/j.intimp.2025.115578_bb0805","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713088","article-title":"Sphingosine-1-phosphate as lung and cardiac vasculature protecting agent in SARS-CoV-2 infection","volume":"24","author":"Karam","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2025.115578_bb0810","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.ijid.2021.05.001","article-title":"Potential value of circulating endothelial cells for the diagnosis and treatment of COVID-19","volume":"107","author":"Zhang","year":"2021","journal-title":"Int. J. Infect. Dis."},{"issue":"10","key":"10.1016\/j.intimp.2025.115578_bb0815","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1007\/s11010-023-04658-7","article-title":"Receptor-dependent effects of sphingosine-1-phosphate (S1P) in COVID-19: the black side of the moon","volume":"478","author":"Al-Kuraishy","year":"2023","journal-title":"Mol. Cell. Biochem."},{"issue":"8","key":"10.1016\/j.intimp.2025.115578_bb0820","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23084343","article-title":"An update on sphingosine-1-phosphate and lysophosphatidic acid receptor transcripts in rodent olfactory mucosa","volume":"23","author":"Toebbe","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.intimp.2025.115578_bb0835","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.jaci.2024.04.031","article-title":"Clinical and humoral response after SARS-CoV-2 breakthrough infection in patients receiving immunosuppressant therapy","volume":"154","author":"Stalman","year":"2024","journal-title":"J. Allergy Clin. Immunol."},{"issue":"6","key":"10.1016\/j.intimp.2025.115578_bb0840","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1007\/s00415-023-11692-4","article-title":"COVID-19 infection after SARS-CoV-2 mRNA vaccination in multiple sclerosis, AQP4-antibody NMOSD and MOGAD patients during the omicron subvariant BA.1\/2 wave in Singapore","volume":"270","author":"Yeo","year":"2023","journal-title":"J. Neurol."},{"key":"10.1016\/j.intimp.2025.115578_bb0845","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2022.105217","article-title":"Cellular and humoral immune response to SARS-CoV-2 vaccination and booster dose in immunosuppressed patients: an observational cohort study","volume":"153","author":"Yang","year":"2022","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.intimp.2025.115578_bb0850","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1450853","article-title":"A blood-based mRNA signature distinguishes people with long COVID from recovered individuals","volume":"15","author":"Missailidis","year":"2024","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.intimp.2025.115578_bb0855","article-title":"Clinical effectiveness of coronavirus disease 2019 vaccination in patients with multiple sclerosis stratified by disease-modifying treatment","volume":"31","author":"De Troyer","year":"2024","journal-title":"Eur. J. Neurol."},{"issue":"10","key":"10.1016\/j.intimp.2025.115578_bb0860","doi-asserted-by":"crossref","first-page":"4632","DOI":"10.1007\/s00415-023-11935-4","article-title":"Risk of breakthrough COVID-19 after vaccination among people with multiple sclerosis on disease-modifying therapies","volume":"270","author":"Spierer","year":"2023","journal-title":"J. Neurol."},{"key":"10.1016\/j.intimp.2025.115578_bb0865","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103554","article-title":"Humoral and cellular immune responses to SARS CoV-2 vaccination in people with multiple sclerosis and NMOSD patients receiving immunomodulatory treatments","volume":"59","author":"Bock","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"4","key":"10.1016\/j.intimp.2025.115578_bb0870","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1136\/jnnp-2022-330100","article-title":"SARS-CoV-2 omicron breakthrough infections in patients with multiple sclerosis","volume":"94","author":"van Kempen","year":"2023","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.intimp.2025.115578_bb0875","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103735","article-title":"Risk of COVID-19 infection and severe disease in MS patients on different disease-modifying therapies","volume":"60","author":"Smith","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"7","key":"10.1016\/j.intimp.2025.115578_bb0880","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1177\/13524585211061343","article-title":"Immunoglobulin G immune response to SARS-CoV-2 vaccination in people living with multiple sclerosis within multiple sclerosis partners advancing technology and health solutions","volume":"28","author":"Cohen","year":"2022","journal-title":"Mult. Scler."},{"key":"10.1016\/j.intimp.2025.115578_bb0885","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.103737","article-title":"Differential antibody response to COVID-19 vaccines across immunomodulatory therapies for multiple sclerosis","volume":"62","author":"Satyanarayan","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"5","key":"10.1016\/j.intimp.2025.115578_bb0890","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1111\/ene.15265","article-title":"Comparing humoral immune response to SARS-CoV2 vaccines in people with multiple sclerosis and healthy controls: an Austrian prospective multicenter cohort study","volume":"29","author":"Bsteh","year":"2022","journal-title":"Eur. J. Neurol."},{"issue":"9","key":"10.1016\/j.intimp.2025.115578_bb0900","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1136\/jnnp-2022-329123","article-title":"Multiple sclerosis disease-modifying therapies and COVID-19 vaccines: a practical review and meta-analysis","volume":"93","author":"Etemadifar","year":"2022","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"12","key":"10.1016\/j.intimp.2025.115578_bb0910","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.165111","article-title":"T cell responses to SARS-CoV-2 vaccination differ by disease-modifying therapy for multiple sclerosis","volume":"8","author":"Wolf","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.intimp.2025.115578_bb0915","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104965","article-title":"Post-vaccination SARS-Cov-2 T-cell receptor repertoires in patients with multiple sclerosis and related disorders","volume":"79","author":"Algu","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"7","key":"10.1016\/j.intimp.2025.115578_bb0920","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.4049\/jimmunol.2101142","article-title":"Cutting edge: effect of disease-modifying therapies on SARS-CoV-2 vaccine-induced immune responses in multiple sclerosis patients","volume":"208","author":"Yuzefpolskiy","year":"2022","journal-title":"J. Immunol."},{"key":"10.1016\/j.intimp.2025.115578_bb0925","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103692","article-title":"T cells as the hoped-for savior for SARS-CoV-2 vaccination during CD20-depleting antibody therapy?: Commentary for: \u201cdiscordant humoral and T cell immune responses to SARS-CoV-2 vaccination in people with multiple sclerosis on anti-CD20 therapy.\u201d","volume":"74","author":"Bsteh","year":"2021","journal-title":"EBioMedicine"},{"key":"10.1016\/j.intimp.2025.115578_bb0930","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104486","article-title":"Evaluation of immunological responses to third COVID-19 vaccine among people treated with sphingosine receptor-1 modulators and anti-CD20 therapy","volume":"70","author":"Katz Sand","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"10","key":"10.1016\/j.intimp.2025.115578_bb0935","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/acn3.51664","article-title":"Hybrid and vaccine-induced immunity against SAR-CoV-2 in MS patients on different disease-modifying therapies","volume":"9","author":"Kister","year":"2022","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.intimp.2025.115578_bb0940","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.104761","article-title":"mRNA versus inactivated virus COVID-19 vaccines in multiple sclerosis: humoral responses and protectivity-does it matter?","volume":"75","author":"T\u00fct\u00fcnc\u00fc","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.intimp.2025.115578_bb0945","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2021.103417","article-title":"SARS-CoV-2 serology among people with multiple sclerosis on disease-modifying therapies after BBIBP-CorV (Sinopharm) inactivated virus vaccination: same story, different vaccine","volume":"57","author":"Etemadifar","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.intimp.2025.115578_bb0950","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104484","article-title":"Longitudinal adaptive immune responses following sequential SARS-CoV-2 vaccinations in MS patients on anti-CD20 therapies and sphingosine-1-phosphate receptor modulators","volume":"70","author":"Sabatino","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.intimp.2025.115578_bb0955","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1081933","article-title":"NVX-CoV2373-induced T- and B-cellular immunity in immunosuppressed people with multiple sclerosis that failed to respond to mRNA and viral vector SARS-CoV-2 vaccines","volume":"14","author":"Mueller-Enz","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.intimp.2025.115578_bb0960","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.897748","article-title":"Case report: variant-specific pre-exposure prophylaxis of SARS-CoV-2 infection in multiple sclerosis patients lacking vaccination responses","volume":"13","author":"Woopen","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2025.115578_bb0965","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S2213-2600(24)00295-9","article-title":"Global, regional, and national burden of pulmonary arterial hypertension, 1990-2021: a systematic analysis for the global burden of disease study 2021","volume":"13","year":"2025","journal-title":"Lancet Respir. Med."},{"issue":"11","key":"10.1016\/j.intimp.2025.115578_bb0975","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1002\/cbin.11682","article-title":"Dysregulated zinc and sphingosine-1-phosphate signaling in pulmonary hypertension: potential effects by targeting of bone morphogenetic protein receptor type 2 in pulmonary microvessels","volume":"45","author":"Tran","year":"2021","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.intimp.2025.115578_bb0980","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.935787","article-title":"Autoimmunity to Sphingosine-1-phosphate-receptors in systemic sclerosis and pulmonary arterial hypertension","volume":"13","author":"Gluschke","year":"2022","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2025.115578_bb0990","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11020553","article-title":"Bronchopulmonary dysplasia in extremely premature infants: a scoping review for identifying risk factors","volume":"11","author":"Ito","year":"2023","journal-title":"Biomedicines"},{"issue":"3","key":"10.1016\/j.intimp.2025.115578_bb0995","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s12013-021-01014-8","article-title":"Hyperoxia-induced S1P(1) signaling reduced angiogenesis by suppression of TIE-2 leading to experimental bronchopulmonary dysplasia","volume":"79","author":"Sudhadevi","year":"2021","journal-title":"Cell Biochem. Biophys."},{"issue":"8","key":"10.1016\/j.intimp.2025.115578_bb1005","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/ppul.24022","article-title":"Tracheal aspirate VEGF and sphingolipid metabolites in the preterm infant with later development of bronchopulmonary dysplasia","volume":"53","author":"Hendricks-Mu\u00f1oz","year":"2018","journal-title":"Pediatr. Pulmonol."},{"key":"10.1016\/j.intimp.2025.115578_bb1010","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115147","article-title":"Emerging delivery approaches for targeted pulmonary fibrosis treatment","volume":"204","author":"Diwan","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.intimp.2025.115578_bb1015","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s43440-025-00725-6","article-title":"Lymphopenia associated with sphingosine 1-phosphate receptor modulators (S1PRMs) in multiple sclerosis: analysis of European pharmacovigilance data","volume":"77","author":"Balzano","year":"2025","journal-title":"Pharmacol. Rep."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925015693?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576925015693?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T04:03:23Z","timestamp":1763697803000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576925015693"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":206,"alternative-id":["S1567576925015693"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115578","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sphingosine-1-phosphate signaling in respiratory diseases: mechanisms and therapeutic perspectives","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2025.115578","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115578"}}